1208233-13-9

Basic information

• Product Name: 4-iodo-2-(3-methylbut-2-en-1-yl)phenyl-3-phenylpropanoate
• Synonyms: 4-iodo-2-(3-methylbut-2-en-1-yl)phenyl-3-phenylpropanoate
• CAS NO: 1208233-13-9
• Molecular Weight: 420.29
• Mol File: 1208233-13-9.mol

Chemical Properties

• CAS DataBase Reference: 4-iodo-2-(3-methylbut-2-en-1-yl)phenyl-3-phenylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-iodo-2-(3-methylbut-2-en-1-yl)phenyl-3-phenylpropanoate(1208233-13-9)
• EPA Substance Registry System: 4-iodo-2-(3-methylbut-2-en-1-yl)phenyl-3-phenylpropanoate(1208233-13-9)

Safety Data

• Hazardous Substances Data: 1208233-13-9(Hazardous Substances Data)

Upstream product

• 151071-03-3 4-iodo-2-(3-methylbut-2-en-1-yl)phenol 
• 645-45-4 hydrocinnamic acid chloride 
• 870-63-3 prenyl bromide 
• 540-38-5 p-Iodophenol 

Downstream Products

• 1208233-15-1 tert-butyl (2E)-3-[3-(3-methylbut-2-en-1-yl)-4-[(3-phenylpropanoyl)oxy]phenyl]prop-2-enoate 

Relevant articles and documents

Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

Aldo-keto reductase 1C3 (AKR1C3) catalyzes the synthesis of 9α,11β-prostaglandin (PG) F2α and PGF2α prostanoids that sustain the growth of myeloid precursors in the bone marrow. The enzyme is overexpressed in acute myeloid leukemia (

HIGHLY SELECTIVE AKR1C3 INHIBITORS AND METHODS OF USE THEREOF

The present invention includes methods and compositions that inhibit AKR1C3 enzymatic activity and consequently reduces androgen receptor (AR) transactivation, AR and prostate specific antigen (PSA) expression levels in, for example, prostate cancer, cast

Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes

The effects of Brazilian green propolis ethanol extract on Cry j1-induced cys-leukotrienes and histamine release from peripheral leukocytes of patients with allergic rhinitis were investigated. One of the key mechanisms for the anti-allergic properties of the extract was revealed to be the suppression of cys-LTs release. Furthermore, a series of propolis components and their phenethyl esters were synthesized and evaluated as inhibitors of cys-LTs release. Artepillin C, baccharin, and kaempferide were the major active components of the ethanol extract. The inhibitory activity of artepillin C phenethyl ester was comparable to that of existing LT synthesis inhibitors. Crown Copyright